Hepatic reactive lymphoid hyperplasia (RLH) and pseudolymphoma are rare conditions characterized by the proliferation of lymphoid tissue in the liver. These benign lesions can often mimic ...

These propositions are presented in Figure 5. Separation of atypical lymphoid proliferation from reactive hyperplasia and malignant lymphomas is shown in Figure 6. However, it should be noted that ...

Hepatic reactive lymphoid hyperplasia is an uncommon benign condition, often found incidentally as a solitary liver lesion. The chronic inflammatory reaction associated with autoimmune conditions and ...

Florid lymphoid hyperplasia in the terminal ileum can present to surgeons as an acute abdominal pain. Only few cases were reported in the literature. Our case illustrates that a rare case of florid ...

Lymphoid proliferations are traditionally thought to be either benign conditions (reactive hyperplasia and lymphadenitis) or malignant lymphomas. However, not all lymphoid lesions at present can ...

Angiolymphoid Hyperplasia with Eosinophilia (ALHE): A rare vascular disorder characterized by the proliferation of blood vessels and lymphoid tissue, often associated with eosinophils. Epithelioid ...

and nodular lymphoid hyperplasia.1-3 The terms “lymphocytic interstitial pneumonia” or “diffuse lymphoid hyperplasia” have sometimes been used for both lymphocytic interstitial pneumonia and ...

At the time of Morson's writing, MALT lymphomas (more recently renamed as marginal zone B cell lymphomas) were categorised as pseudo-lymphomas, a heterogeneous spectrum of histological abnormalities, ...

Their relevance in the pathogenesis of UC is, however, unknown. We have performed a comprehensive analysis of the immune cells in these aggregates most likely corresponding to the lymphoid follicular ...

Filgotinib maleate is under clinical development by Alfasigma and currently in Phase I for Giant Lymph Node Hyperplasia (Castleman’s Disease). According to GlobalData, Phase I drugs for Giant Lymph ...